Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.1276 EUR
113.21 M EUR
509.17 M EUR
254.51 M
About China Shineway Pharmaceutical Group Limited
Sector
Industry
Website
Headquarters
Shijiazhuang
Founded
2002
IPO date
Dec 2, 2004
Identifiers
3
ISIN KYG2110P1000
China Shineway Pharmaceutical Group Ltd. is an investment holding company, which engages in the research and development, manufacturing, and trading of Chinese pharmaceutical products. Its products include Shen Mai injection, Qing Kai Ling injection, and Wu Fu Xin Nao Qing soft capsule. The company was founded by Zhen Jiang Li and Yun Xia Xin on August 14, 2002 and is headquartered in Shijiazhuang, China.
Related stocks
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
513200
E Fund CSI HK Connect Health Care Composite Exchange Traded Fund UnitsWeight
0.22%
Market value
709.39 K
USD
LDEM
L&G Emerging Markets Quality Dividends Equal Weight UCITS ETFWeight
0.10%
Market value
44.82 K
USD
159776
Yinhua CSI HK Connect Health Care Composite Exchange Traded Fund UnitsWeight
0.21%
Market value
33.92 K
USD
Explore more ETFs
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange China Shineway Pharmaceutical Group Limited stocks are traded under the ticker C1S.
We've gathered analysts' opinions on China Shineway Pharmaceutical Group Limited future price: according to them, C1S price has a max estimate of 1.10 EUR and a min estimate of 1.10 EUR. Watch C1S chart and read a more detailed China Shineway Pharmaceutical Group Limited stock forecast: see what analysts think of China Shineway Pharmaceutical Group Limited and suggest that you do with its stocks.
Yes, you can track China Shineway Pharmaceutical Group Limited financials in yearly and quarterly reports right on TradingView.
China Shineway Pharmaceutical Group Limited is going to release the next earnings report on Mar 31, 2026. Keep track of upcoming events with our Earnings Calendar.
C1S net income for the last half-year is 71.38 M EUR, while the previous report showed 28.80 M EUR of net income which accounts for 147.84% change. Track more China Shineway Pharmaceutical Group Limited financial stats to get the full picture.
China Shineway Pharmaceutical Group Limited dividend yield was 6.02% in 2024, and payout ratio reached 48.19%. The year before the numbers were 6.48% and 33.21% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Feb 1, 2026, the company has 3.22 K employees. See our rating of the largest employees — is China Shineway Pharmaceutical Group Limited on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. China Shineway Pharmaceutical Group Limited EBITDA is 92.56 M EUR, and current EBITDA margin is 23.95%. See more stats in China Shineway Pharmaceutical Group Limited financial statements.
Like other stocks, C1S shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade China Shineway Pharmaceutical Group Limited stock right from TradingView charts — choose your broker and connect to your account.